Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Miao Gen Files Initial Ownership Form as Jinko Holdings Director

Director Miao Gen filed an initial statement of beneficial ownership with the SEC on November 9, 2026, disclosing no securities held in Jinko Holdings Ltd as of the event date of October 30, 2026.

Aakashdeep | 09 November 2026

Kun Zhang Files Initial Ownership Form as Acting CFO

Kun Zhang, Acting Chief Financial Officer of Jinko Holdings Ltd, filed an initial statement of beneficial ownership on November 9, 2026, with a triggering event date of October 30, 2026.

Anjali Anand | 09 November 2026

AA Mission Acquisition Corp. II (NYSE:YCY) Near 52-Week High: Net Income of USD 972,318 for the Quarter

AA Mission Acquisition Corp. II is a blank check company incorporated in the Cayman Islands and headquartered in The Woodlands, Texas. It was formed to effect a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. …

Nitish Kishor | 09 November 2026

AerCap (NYSE:AER) Near 52-Week High: Third Quarter Adjusted EPS of USD 6.56 and Raised 2026 Guidance

AerCap is an aviation leasing company that buys, leases and sells aircraft and manages aviationAssetsthrough their life cycle. It has been a public company for two decades, and it holds BBB+ and Baa1Creditratings. AerCap has a marketCapitalizationof USD 26.2 billion and a price to …

Nitish Kishor | 09 November 2026

What Investors Are Watching at Amphastar (NASDAQ:AMPH) Near a 52-Week High: FDA Warning Letter and Product Launches

Based in Rancho Cucamonga, California, Amphastar is a Delaware corporation that develops, manufactures and sells generic and proprietary injectable, inhalation and intranasal products, along with active pharmaceutical ingredient products. It manufactures and sells more than 30 prescription and over-the-counter products, including BAQSIMI, Primatene MIST, …

Nitish Kishor | 09 November 2026

Ardent Health (NYSE:ARDT) Climbs 9% Near 52-Week High as Third Quarter Turns Profitable

Based in Brentwood, Tennessee, Ardent was formed in Delaware in 2015 and converted into a Delaware corporation in July 2024 in connection with its initial public offering. The holding company's affiliates operate acute care hospitals and other healthcare facilities and employ physicians, and at …

Nitish Kishor | 09 November 2026

Arhaus (NASDAQ:ARHS) Up 9.66% Near 52-Week High: Third Quarter Comparable Written Sales Rise 13.9%

Based in Boston Heights, Ohio, Arhaus is a Delaware corporation and a premium home furnishingsBrandwith a vertically integrated model that covers design, direct sourcing and upholsteryManufacturingat its own North Carolina facility. It sells furniture, outdoor, bath, lighting, textiles and decor through 109 showrooms and …

Nitish Kishor | 09 November 2026

Ashland (NYSE:ASH) Near 52-Week High: Fiscal Fourth Quarter Sales of USD 498 Million and Fiscal 2027 Outlook

Based in Wilmington, Delaware, Ashland describes itself as a global additives and specialty ingredients company withLeadershippositions in consumer-focused markets. Its businesses are Life Sciences, Personal Care, Specialty Additives and Intermediates. Ashland has a marketCapitalizationof USD 3.51 billion and a price toEarningsratio of 880.69, and …

Nitish Kishor | 09 November 2026

Avita Medical (NASDAQ:RCEL) Near 52-Week High: Third Quarter Revenue Climbs 53% to USD 26.1 Million

Avita Medical is a Delaware corporation based in Valencia, California, and a leading therapeutic acute wound care company. Its solutions address the healing needs of patients with traumatic injuries and surgical repairs. Avita Medical has a marketCapitalizationof USD 513.08 million and no reported price …

Nitish Kishor | 09 November 2026

Why Is Becton Dickinson (NYSE:BDX) Near a 52-Week High After Fiscal Fourth Quarter Revenue Rose 5.4%?

Based in Franklin Lakes, New Jersey, BD is a New Jersey corporation and a global medical technology company that operates four separately managed segments after the elimination of its Life Sciences segment, including Medical Essentials and Connected Care. Its portfolio includes the Alaris infusion …

Nitish Kishor | 09 November 2026
Support

Hi! How can we help you today?

Loading…